| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.0008 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.002 |